Hayasaki, A., Murata, Y., Usui, M., Hibi, T., Fujii, T., Iizawa, Y., . . . Isaji, S. (2019). Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes. Biomed Res Int.
Citação norma ChicagoHayasaki, Aoi, et al. "Clinical Significance of Plasma Apolipoprotein-AII Isoforms As a Marker of Pancreatic Exocrine Disorder for Patients With Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes." Biomed Res Int 2019.
MLA引文Hayasaki, Aoi, et al. "Clinical Significance of Plasma Apolipoprotein-AII Isoforms As a Marker of Pancreatic Exocrine Disorder for Patients With Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes." Biomed Res Int 2019.